NextCure | 10-Q:季度报表
NextCure | 8-K:NextCure提供业务更新并报告2024年第一季度财务业绩
NextCure | DEF 14A:股东委托书决议
NextCure | DEFA14A:其他
NextCure | PRE 14A:并购重组委托声明
NextCure | 4:持股变动声明-高管 Shaw Kevin G.
NextCure | 4:持股变动声明-高管 Richman Michael
NextCure | 4:持股变动声明-高管 Mayer Timothy
NextCure | 4:持股变动声明-高管 Myint Han
NextCure | 4:持股变动声明-高管 Langermann Sol
NextCure | 4:持股变动声明-高管 Kundu Sourav
NextCure | 4:持股变动声明-高管 Cobourn Steven P.
NextCure | SC 13G:超过5%持股股东披露文件-Logos Global Management LP(7.2%),Logos Global Management GP LLC(7.2%)等
NextCure | 10-K:年度报表
NextCure | 8-K:重大事件
NextCure | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Advisors LLC(4.5%),OrbiMed Capital GP VI LLC(4.5%)
NextCure | 4:持股变动声明-高管 Langermann Sol
NextCure | 4:持股变动声明-高管 Mayer Timothy
NextCure | 4:持股变动声明-高管 Myint Han
NextCure | 4:持股变动声明-高管 Richman Michael
暂无数据